Prime Capital Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
19,680
-3,419
| -15% | -$239K | 0.02% | 408 |
|
|
2025
Q1 | $1.7M | Buy |
23,099
+3,028
| +15% | +$223K | 0.02% | 394 |
|
|
2024
Q4 | $1.32M | Sell |
20,071
-2,017
| -9% | -$132K | 0.02% | 376 |
|
|
2024
Q3 | $1.72M | Sell |
22,088
-2,068
| -9% | -$161K | 0.02% | 336 |
|
|
2024
Q2 | $1.88M | Sell |
24,156
-1,428
| -6% | -$111K | 0.03% | 321 |
|
|
2024
Q1 | $1.73M | Sell |
25,584
-620
| -2% | -$42K | 0.02% | 367 |
|
|
2023
Q4 | $1.76M | Buy |
26,204
+10,113
| +63% | +$681K | 0.03% | 347 |
|
|
2023
Q3 | $1.09M | Buy |
16,091
+104
| +0.7% | +$7.04K | 0.02% | 330 |
|
|
2023
Q2 | $1.14M | Buy |
15,987
+7,927
| +98% | +$567K | 0.02% | 335 |
|
|
2023
Q1 | $559K | Buy |
8,060
+2,885
| +56% | +$200K | 0.02% | 326 |
|
|
2022
Q4 | $351K | Buy |
5,175
+1,503
| +41% | +$102K | 0.01% | 394 |
|
|
2022
Q3 | $201K | Buy |
3,672
+86
| +2% | +$4.71K | 0.01% | 382 |
|
|
2022
Q2 | $237K | Buy |
+3,586
| New | +$237K | 0.01% | 328 |
|
|
2021
Q2 | – | Sell |
-870
| Closed | -$43K | – | 392 |
|
|
2021
Q1 | $43K | Sell |
870
-139
| -14% | -$6.87K | ﹤0.01% | 348 |
|
|
2020
Q4 | $50K | Buy |
1,009
+132
| +15% | +$6.54K | ﹤0.01% | 320 |
|
|
2020
Q3 | $48K | Buy |
877
+2
| +0.2% | +$109 | ﹤0.01% | 319 |
|
|
2020
Q2 | $46K | Buy |
875
+17
| +2% | +$894 | ﹤0.01% | 329 |
|
|
2020
Q1 | $38K | Sell |
858
-5
| -0.6% | -$221 | ﹤0.01% | 300 |
|
|
2019
Q4 | $43K | Buy |
863
+101
| +13% | +$5.03K | ﹤0.01% | 318 |
|
|
2019
Q3 | $34K | Buy |
+762
| New | +$34K | 0.01% | 343 |
|
|
2018
Q3 | – | Sell |
-3,424
| Closed | -$120K | – | 258 |
|
|
2018
Q2 | $120K | Buy |
3,424
+1,244
| +57% | +$43.6K | 0.05% | 147 |
|
|
2018
Q1 | $76K | Hold |
2,180
| – | – | 0.05% | 147 |
|
|
2017
Q4 | $76K | Buy |
+2,180
| New | +$76K | 0.06% | 143 |
|